Senior couple enjoying seaside conversation

Home / News / FDA

FDA · July 6, 2026

FDA clears Cytrans™ Elashield (GC America, Inc.)

The FDA cleared Cytrans™ Elashield, a synthetic bone grafting material from GC America, Inc. (Alsip, US), under 510(k) K253317 on July 6, 2026.

Source
U.S. FDA 510(k) database
accessdata.fda.gov
Published
July 6, 2026
Type
FDA
Checked
October 2, 2026

Read the source

Featured

Featured doctor

Featured doctors advertise with the publisher. Featured placement does not change a score or a rank. Disclosure

Dr. Michael Pawlus
Featured

ICOI Fellow, ICOI Diplomate · AAP member

Featured doctorDr. Michael Pawlus · Sarasota